Webinar : Worldwide Clinical Experience of Sudoscan In the Managment and Prevention of Diabetes Complications – November the 14th 2024
Meet Sudoscan at the 60th EASD Congress 2024
Meet Sudoscan at the 34th NEUROdiab Meeting 2024
Meet Sudoscan at the 10th EAN Congress 2024
Webinar : Small fibers neuropathy in various neurological condition – May the 30th 2024
Sudoscan and Withings at the 20th Malvern Diabetic Foot Conference
About Sudoscan
Impeto Medical is a medical device company part of WITHINGS company. Created in June 2005, its corporate headquarters are located close to Paris, France; the company is also present in San Diego, CA, USA.
COPYRIGHT 2005-2024 – IMPETO MEDICAL © All rights reserved.
Sudoscan in the world
More information
Contact info
Promotional Communication. The medical devices SUDOSCAN & EZSCAN are regulated health products under the CE certification, Class IIa, according to the European Medical Device directive – SGS Belgium, notified body 1639. The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12
